929697-01-8

Upstream product

• 930579-53-6 (2S,3S)-3-[1-benzyl-3-(tert-butyldimethylsilanyloxy)-2-methyl-6-oxo-1,2,3,6-tetrahydropyridin-4-yl]propionic acid methyl ester 
• 930579-54-7 (5S,6S)-1-benzyl-5-(tert-butyldimethylsilanyloxy)-4-(3-hydroxypropyl)-6-methyl-5,6-dihydro-1H-pyridin-2-one 
• 898831-82-8 (2S,3S)-3-[benzyl(2-nitrobenzenesulfonyl)amino]-2-(tert-butyldimethylsilanyloxy)butyric acid ethyl ester 
• 930579-51-4 (2S,3S)-3-(benzylethoxycarbonylacetylamino)-2-(tert-butyldimethylsilanyloxy)butyric acid ethyl ester 
• 930579-52-5 (5S,6S)-1-benzyl-5-(tert-butyldimethylsilanyloxy)-6-methyl-4-trifluoromethanesulfonyloxy-5,6-dihydro-1H-pyridin-2-one 
• 930579-56-9 acetic acid (2S,3S)-1-benzyl-4-(3-iodo-propyl)-2-methyl-6-oxo-1,2,3,6-tetrahydropyridin-3-yl ester 

Downstream Products

• 930579-59-2 (1S)-2-[(2S)-2-(benzyl-tert-butoxycarbonylamino)propylidene]cyclopentanecarboxylic acid methyl ester 

Relevant academic research and scientific papers

Synthesis of (Z)-alkene-containing cis-proline dipeptide mimetics using samarium(II) diiodide (SmI2)-mediated reductive alkylation reaction

The amide bond between an amino acid and proline can take the trans- or cis-conformation. The conformation influences both the structure and function of peptides and proteins. Therefore, constrained mimetic, which corresponds to Pro-dipeptides whose amide